Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Thymogen structure

Thymogen

Immune
Phase 2 Research
45%
Low Risk
1/5

Dosing Protocol

Typical Dose 250 mcg
Range 100 - 500 mcg
Maintenance 250 mcg daily
Cycle 2w on / 8w off

Pharmacokinetics

Half-Life 30 min
Onset 15 min
Peak 45 min
Duration 4.0 hrs
Bioavailability 71%
Primary Route Nasal

Administration

Routes Nasal, Intramuscular, Topical
Injection Sites Deltoid, Thigh
Needle Gauge 29-31G
Syringe Type Nasal Spray
Timing Morning

Reconstitution

Diluent Sterile Water
Volume 1 mL
Stability 30 days refrigerated

Special Instructions

Nasal spray is most convenient - 71% bioavailability. Accumulates in thymus and lymph nodes. Russian medical registration since 1990. Topical cream available for wound healing.